Next Generation News and Research

RSS

MD Anderson Cancer Center and 4D pharma team up to evaluate live biotherapeutic oncology pipeline

The University of Texas MD Anderson Cancer Center and 4D pharma today announced a strategic collaboration to evaluate 4D's live biotherapeutic oncology pipeline across a range of cancer settings.

7 Jan 2019

Using Assay Kits and Dyes to Advance Cell Biology Research

In this interview, Richard Delle Bovi highlights live cell ability of the CELLESTIAL® analysis kit from Enzo Life Sciences and its applications in cell biology.

From Enzo Life Sciences, Inc. 2 Jan 2019

Researchers conduct cohort trial to determine most preferred SOGI collection method

Health care and government organizations call for routine collection of sexual orientation and gender identity information in the clinical setting.

31 Dec 2018

Insilico to present 'AI-powered end-to-end pipelines for drug discovery' at Longevity Therapeutics 2019

Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence, will present its latest results in modern and next-generation AI for Drug Discovery at The Longevity Therapeutics 2019 in San Francisco, 30 of January.

30 Dec 2018

Genetically diverse mouse models improves usability for precision medicine for Alzheimer's

Incorporating genetic diversity into a mouse model of Alzheimer's disease resulted in greater overlap with the genetic, molecular and clinical features of this pervasive human disease, according to a study funded by the National Institute on Aging, part of the National Institutes of Health.

28 Dec 2018

White colonies on kimchi surface is not formed by molds but by yeasts, finds study

WiKim reported that the white colonies on the surface of kimchi is not formed by molds but by "yeasts" and that genomic data was acquired regarding the hygienic safety of the yeast strains.

27 Dec 2018

Cell-free DNA can be used to predict biological age, according to a new study

Scientists have found that cell-free DNA (cfDNA) within in the blood can reflect differences in the age and health of individuals.

21 Dec 2018

New project develops more efficient treatment approaches for cardiovascular diseases

Within the framework of a European collaborative research project, Oliver Müller, professor at the Faculty of Medicine at Kiel University and Consultant at the Department of Internal Medicine III, University Medical Center Schleswig-Holstein, Campus Kiel, will receive 1.4 million Euros for the project "CardioReGenix: Development of Next-Generation Gene Therapies for Cardiovascular Disease".

21 Dec 2018

Advanced stem cell approach could help fight Parkinson's disease

Scientists have taken a key step towards improving an emerging class of treatments for Parkinson's disease.

20 Dec 2018

Current progress on highly sensitive and flexible nano-structured materials

Advancement in technology is making life easier. However, innovation in nano-materials has made them important enough and now they are represented as the most promising class of new materials due to their intriguing optical, electronic and redox properties.

20 Dec 2018

FAU Brain Institute fellows awarded $1.1 million for Alzheimer's disease research

In Florida, there are more than 540,000 people living with Alzheimer's disease (AD), the most recognized form of dementia. The number of people in Florida who are age 65 and older with AD is expected to increase 41.2 percent by 2025 to a projected 720,000, highlighting the urgency of finding medical and treatment breakthroughs.

19 Dec 2018

MUSC researchers identify potential therapeutic target for lung fibrosis

In an article published online by Frontiers in Endocrinology, researchers at the Medical University of South Carolina report that they have identified a potential therapeutic target for lung fibrosis or scarring.

19 Dec 2018

Personalization techniques give a new lease of life to anticancer vaccines

Anticancer vaccines have gained a new lease of life with techniques to personalise them to individual patients.

19 Dec 2018

Horizon Discovery partners with C4XD to validate novel synthetic lethal oncology targets

Horizon Discovery Group today announces that it has entered into an exclusive target discovery partnership with C4XD, a pioneering drug discovery company.

From Revvity 19 Dec 2018

Developing the Next Generation of Water-soluble DREADDs

An interview with James Flanaghan, discussing the uses of DREADDs in neurobiological research and the advantages of water-soluble ligands.

From Hello Bio 19 Dec 2018

Research explores effects of cannabis use on males’ reproductive health

As legal access to marijuana continues expanding across the U.S., more scientists are studying the effects of its active ingredient, tetrahydrocannabinol (THC), in teens, adults and pregnant women.

19 Dec 2018

Netsmart, Kindred Healthcare team up to create unique, technology-driven post-acute platform

Kindred Healthcare, LLC and Netsmart today announced a partnership to create a unique, technology-driven clinical platform that surpasses the traditional boundaries of electronic medical records and aligns with the needs of the evolving value-based care environment.

19 Dec 2018

Quidel receives CE mark to use Sofia 2 Lyme+ Fluorescent Immunoassay with Sofia 2 analyzer

Quidel Corporation, a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received CE Mark to market Quidel's Sofia 2 Lyme+ FIA to be used with the Sofia 2 Fluorescent Immunoassay Analyzer for the rapid differential detection of human IgM and IgG antibodies to Borrelia burgdorferi, Borrelia garinii, and Borrelia afzelii from serum and plasma specimens.

19 Dec 2018

Combination of a vaccine and checkpoint drugs reduces pancreatic tumors in mice

Researchers at the Johns Hopkins Kimmel Cancer Center discovered a combination of a cancer vaccine with two checkpoint drugs reduced pancreatic cancer tumors in mice, demonstrating a possible pathway for treatment of people with pancreatic cancers whose response to standard immunotherapy is poor.

18 Dec 2018

New compound blocks genetic cause of familial ALS and frontotemporal dementia

Since the ice bucket challenge went viral in 2014, raising awareness and funding for ALS research, scientists have learned much about a disease that disconnects muscles from nerves, leading to muscle atrophy and eventual death. Their ultimate goal is to create medications capable of stopping ALS in its tracks.

18 Dec 2018

Next Generation News and Research

MD Anderson Cancer Center and 4D pharma team up to evaluate live biotherapeutic oncology pipeline

Using Assay Kits and Dyes to Advance Cell Biology Research

Researchers conduct cohort trial to determine most preferred SOGI collection method

Insilico to present 'AI-powered end-to-end pipelines for drug discovery' at Longevity Therapeutics 2019

Genetically diverse mouse models improves usability for precision medicine for Alzheimer's

White colonies on kimchi surface is not formed by molds but by yeasts, finds study

Cell-free DNA can be used to predict biological age, according to a new study

New project develops more efficient treatment approaches for cardiovascular diseases

Advanced stem cell approach could help fight Parkinson's disease

Current progress on highly sensitive and flexible nano-structured materials

FAU Brain Institute fellows awarded $1.1 million for Alzheimer's disease research

MUSC researchers identify potential therapeutic target for lung fibrosis

Personalization techniques give a new lease of life to anticancer vaccines

Horizon Discovery partners with C4XD to validate novel synthetic lethal oncology targets

Developing the Next Generation of Water-soluble DREADDs

Research explores effects of cannabis use on males’ reproductive health

Netsmart, Kindred Healthcare team up to create unique, technology-driven post-acute platform

Quidel receives CE mark to use Sofia 2 Lyme+ Fluorescent Immunoassay with Sofia 2 analyzer

Combination of a vaccine and checkpoint drugs reduces pancreatic tumors in mice

New compound blocks genetic cause of familial ALS and frontotemporal dementia

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News